CONDENSED BALANCE SHEETS - USD ($)		Dec. 31, 2023	Dec. 31, 2022
Current Assets:
Cash		$ 1,905,123	$ 0
Prepaid expenses		509,950	1,200
Total current assets		2,415,073	1,200
Investments held in Trust Account		523,038,352	0
Deferred offering costs		0	511,395
Total assets		525,453,425	512,595
Current liabilities:
Accrued expenses		271,633	270,391
Due to related party		7,500	0
Liabilities, Current		279,133	503,634
Overfunding loans		5,000,000	0
Deferred underwriting and advisory fees		17,500,000	0
Total liabilities		22,779,133	503,634
Commitments and contingencies
Shareholders’ equity (deficit)
Class A ordinary shares subject to possible redemption as of December 31, 2023		522,938,352	0
Preference shares, $0.0001 par value; 99,990,000 shares authorized(1); none issued or outstanding	[1]	0	0
Additional paid-in capital		0	23,750
Accumulated deficit		(20,265,310)	(16,039)
Total shareholders’ equity (deficit)		(20,264,060)	8,961
Total liabilities and shareholders’ equity (deficit)		$ 525,453,425	$ 512,595
Other Liability, Current, Related Party, Type [Extensible Enumeration]		Related Party	Related Party
Related Party
Current liabilities:
Promissory note		$ 0	$ 233,243
Due to related party		7,500	0
Common Class A
Shareholders’ equity (deficit)
Ordinary shares	[1]	$ 0	$ 0
Redemption price (in dollars per share)		$ 10.46	$ 0.00
Outstanding shares subject to redemption (in shares)		50,000,000	0
Common Class B
Shareholders’ equity (deficit)
Ordinary shares	[1],[2]	$ 1,250	$ 1,250

[1] On April 20, 2023, the Company increased the authorized share capital of the Company. All shares as of December 31, 2022 have been retroactively restated to reflect such increase (see Note 6).

[2] (2) On April 25, 2023, the Company consummated the sale of Over-Allotment Units pursuant to the underwriters’ partial exercise of their over-allotment option. Share amounts as of December 31, 2022 have been retroactively restated to reflect the share surrender and share recapitalization events (see Note 4).